These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24835435)

  • 1. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
    Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
    Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
    Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
    Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
    Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
    Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
    Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.
    Mayer O; Seidlerová J; Wohlfahrt P; Filipovský J; Vaněk J; Cífková R; Windrichová J; Topolčan O; Knapen MH; Drummen NE; Vermeer C
    J Hum Hypertens; 2016 Jul; 30(7):418-23. PubMed ID: 26016598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and stroke.
    Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Verschuren WM; Boer JM; Beulens JW
    J Thromb Haemost; 2014 Jul; 12(7):1028-34. PubMed ID: 24826813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.
    Liu YP; Gu YM; Thijs L; Knapen MH; Salvi E; Citterio L; Petit T; Carpini SD; Zhang Z; Jacobs L; Jin Y; Barlassina C; Manunta P; Kuznetsova T; Verhamme P; Struijker-Boudier HA; Cusi D; Vermeer C; Staessen JA
    Hypertension; 2015 Feb; 65(2):463-70. PubMed ID: 25421980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients.
    Mayer O; Bruthans J; Seidlerová J; Karnosová P; Mateřánková M; Gelžinský J; Rychecká M; Opatrný J; Wohlfahrt P; Kučera R; Trefil L; Cífková R; Filipovský J; Vermeer C
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):540-551. PubMed ID: 33257192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K status and mortality after kidney transplantation: a cohort study.
    Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
    Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
    Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
    Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
    Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
    Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.
    Schurgers LJ; Barreto DV; Barreto FC; Liabeuf S; Renard C; Magdeleyns EJ; Vermeer C; Choukroun G; Massy ZA
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):568-75. PubMed ID: 20133489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population.
    Wei FF; Thijs L; Zhang ZY; Jacobs L; Yang WY; Salvi E; Citterio L; Cauwenberghs N; Kuznetsova T; E A Drummen N; Hara A; Manunta P; Li Y; Verhamme P; Allegaert K; Cusi D; Vermeer C; Staessen JA
    Nephrol Dial Transplant; 2018 Mar; 33(3):514-522. PubMed ID: 28340119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
    Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Verschuren WM; Boer JM; Beulens JW
    Diabetes Care; 2013 Nov; 36(11):3766-71. PubMed ID: 23877986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix Gla Protein, Plaque Stability, and Cardiovascular Events in Patients with Severe Atherosclerotic Disease.
    Zwakenberg SR; van der Schouw YT; Vermeer C; Pasterkamp G; den Ruijter HM; Beulens JWJ
    Cardiology; 2018; 141(1):32-36. PubMed ID: 30304721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.